Related Experiment Video

Updated: Aug 16, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Efficacy and safety of ciprofibrate in hyperlipoproteinaemias

G Turpin1, E Bruckert

  • 1Department of Endocrinology and Metabolism, Pitié-Salpétrière Hospital Center, Paris, France.

Atherosclerosis
|July 1, 1996
PubMed

Insights

Ciprofibrate effectively treats atherogenic hyperlipoproteinaemia, lowering cholesterol and triglycerides. This medication improves lipid profiles in patients with hypercholesterolaemia and hypertriglyceridaemia.

Area of Science:

  • Cardiology
  • Pharmacology
  • Metabolic Disorders

Background:

  • Atherogenic hyperlipoproteinaemia encompasses conditions like hypercholesterolaemia and hypertriglyceridaemia.
  • Effective lipid-lowering therapies are crucial for managing cardiovascular risk.

Purpose of the Study:

  • To evaluate the efficacy of ciprofibrate in treating specific types of atherogenic hyperlipoproteinaemia.
  • To analyze the effects of ciprofibrate on lipid profiles and apolipoproteins.

Main Methods:

  • Clinical study involving approximately 7300 patients with type IIa, IIb, and IV hyperlipoproteinaemia.
  • Administration of ciprofibrate at a dosage of 100 mg/day.
  • Monitoring of total cholesterol, triglycerides, LDL cholesterol, HDL cholesterol, apolipoprotein B, and apolipoprotein AI levels.

Main Results:

  • Ciprofibrate significantly decreased total cholesterol, triglycerides, and LDL cholesterol in type IIa and IIb hyperlipoproteinaemia.
  • The drug increased HDL cholesterol and apolipoprotein AI levels.
  • In type IV hypertriglyceridaemia, ciprofibrate reduced total cholesterol primarily by lowering triglycerides and increasing HDL cholesterol.

Conclusions:

  • Ciprofibrate demonstrates efficacy in managing type IIa, IIb, and IV hyperlipoproteinaemia.
  • The drug favorably modulates key lipid parameters, including LDL and HDL cholesterol.
  • Further discussion includes ciprofibrate's pharmacokinetics, mechanism of action, and safety profile.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...